Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Biotage acquires Vapourtec line

January 23, 2006 | A version of this story appeared in Volume 84, Issue 4

The drug discovery technology firm Biotage has acquired rights to Vapourtec's solvent evaporation system, known as V-10. It will pay up to $4 million for a business that is expected to have sales next year of $5 million to $10 million. "Evaporation presents a major bottleneck in chemistry and drug development," says Biotage CEO Jeff Bork. "V-10 substantially reduces sample drying time for pharmaceutical chemists." Biotage acquired the chemical synthesis equipment firm Argonaut Technologies last year.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.